Yifan Zhai
Hebei Medical University(CN)Nanjing University of Chinese Medicine(CN)Shandong University of Traditional Chinese Medicine(CN)Yanbian University(CN)Peking University(CN)Zhengzhou University of Light Industry(CN)ProQuest (United States)(US)Fourth Hospital of Hebei Medical University(CN)Zhejiang Police College(CN)Flow Pharma (United States)(US)Ascendis Pharma (Denmark)(DK)Peking University People's Hospital(CN)Department of Health of Guangdong Province(CN)Bridge Pharma (United States)(US)Vifor Pharma (United States)(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Cancer-related Molecular Pathways
Most-Cited Works
- → LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response(2000)396 cited
- → A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis(1999)367 cited
- → Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-κB, and c-Jun NH2-Terminal Kinase(1999)320 cited
- → Immunizing Patients With Metastatic Melanoma Using Recombinant Adenoviruses Encoding MART-1 or gp100 Melanoma Antigens(1998)305 cited
- → Discovery of 4-((3′R,4′S,5′R)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development(2017)194 cited